Single User License
INR 170050
Site License
INR 340100
Corporate User License
INR 510150

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Growth Hormone Deficiency Global Clinical Trials Review, H1

Growth Hormone Deficiency Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Growth Hormone Deficiency Global Clinical Trials Review, H1, 2015" provides an overview of Growth Hormone Deficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Growth Hormone Deficiency . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Growth Hormone Deficiency 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Growth Hormone Deficiency 25

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Growth Hormone Deficiency Therapeutics Clinical Trials 32

Prominent Drugs 33

Latest Clinical Trials News on Growth Hormone Deficiency 34

Jun 25, 2015: Aeterna Zentaris Announces Selection of Ergomed to Conduct Confirmatory Phase 3 Clinical Trial of Macrilen in AGHD 34

May 26, 2015: Aeterna Zentaris' Confirmatory Phase 3 Study for Macrilen in AGHD Meets EMA's Study-Design Expectations 34

Apr 13, 2015: Aeterna Zentaris Announces Plans to Initiate Phase 3 Study of Macrilen in AGHD Following Successful Meeting with FDA 35

Apr 13, 2015: Versartis Initiates Phase 2/3 Trial of VRS-317 in Japan for Children With Growth Hormone Deficiency 35

Clinical Trial Profiles 37

Clinical Trial Overview of Top Companies 37

Novo A/S 37

Clinical Trial Overview of Novo A/S 37

Pfizer Inc. 40

Clinical Trial Overview of Pfizer Inc. 40

Eli Lilly and Company 42

Clinical Trial Overview of Eli Lilly and Company 42

F. Hoffmann-La Roche Ltd. 43

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 43

Canbex Therapeutics Ltd. 44

Clinical Trial Overview of Canbex Therapeutics Ltd. 44

E. Merck KG 45

Clinical Trial Overview of E. Merck KG 45

LG Life Sciences, Ltd. 46

Clinical Trial Overview of LG Life Sciences, Ltd. 46

Ferring International Center S.A. 47

Clinical Trial Overview of Ferring International Center S.A. 47

Teva Pharmaceutical Industries Limited 48

Clinical Trial Overview of Teva Pharmaceutical Industries Limited 48

OPKO Health, Inc. 49

Clinical Trial Overview of OPKO Health, Inc. 49

Clinical Trial Overview of Top Institutes / Government 50

Aarhus University 50

Clinical Trial Overview of Aarhus University 50

Federico II University 51

Clinical Trial Overview of Federico II University 51

Massachusetts General Hospital 52

Clinical Trial Overview of Massachusetts General Hospital 52

Oregon Health & Science University 53

Clinical Trial Overview of Oregon Health & Science University 53

Columbia University 54

Clinical Trial Overview of Columbia University 54

Eunice Kennedy Shriver National Institute of Child Health and Human Development 55

Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 55

Sahlgrenska University Hospital 56

Clinical Trial Overview of Sahlgrenska University Hospital 56

University of Pennsylvania 57

Clinical Trial Overview of University of Pennsylvania 57

Aarhus University Hospital 58

Clinical Trial Overview of Aarhus University Hospital 58

Assaf-Harofeh Medical Center 59

Clinical Trial Overview of Assaf-Harofeh Medical Center 59

Five Key Clinical Profiles 60

Appendix 90

Abbreviations 90

Definitions 90

Research Methodology 91

Secondary Research 91

About GlobalData 92

Contact Us 92

Disclaimer 92

Source 93

List of Figures

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Growth Hormone Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Growth Hormone Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Growth Hormone Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Growth Hormone Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Growth Hormone Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14

Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015* 15

Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015* 18

Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Growth Hormone Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30

Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

GlobalData Methodology 91

List of Tables

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Region, 2015* 7

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Growth Hormone Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Growth Hormone Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Growth Hormone Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Growth Hormone Deficiency Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Growth Hormone Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14

Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, G7 Countries (%), 2015* 15

Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Growth Hormone Deficiency Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Growth Hormone Deficiency to Metabolic Disorders Clinical Trials, E7 Countries (%), 2015* 18

Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Growth Hormone Deficiency Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Growth Hormone Deficiency Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Growth Hormone Deficiency Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Growth Hormone Deficiency Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Growth Hormone Deficiency Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Growth Hormone Deficiency Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29

Growth Hormone Deficiency Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30

Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31

Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32

Growth Hormone Deficiency Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 37

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 40

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 42

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 43

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Canbex Therapeutics Ltd., 2015* 44

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by E. Merck KG, 2015* 45

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2015* 46

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 47

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2015* 48

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by OPKO Health, Inc., 2015* 49

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2015* 50

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Federico II University, 2015* 51

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 52

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health & Science University, 2015* 53

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Columbia University, 2015* 54

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 55

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2015* 56

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2015* 57

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University Hospital, 2015* 58

Growth Hormone Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2015* 59

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novo A/S

Pfizer Inc.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Canbex Therapeutics Ltd.

E. Merck KG

LG Life Sciences, Ltd.

Ferring International Center S.A.

Teva Pharmaceutical Industries Limited

OPKO Health, Inc.

Growth Hormone Deficiency Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Growth Hormone Deficiency, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com